Angiogenesis is critical for re-establishing the blood supply to the surviving myocardium after myocardial infarction (MI) in patients with acute coronary syndrome (ACS).
| INTRODUCTION
Acute coronary syndrome (ACS) remains a major cause of morbidity and mortality worldwide, in which ischaemic complication represents the leading cause in cardiovascular diseases, such as hypertension and atherosclerosis. 1 Angiogenesis is critical for re-establishing the blood supply to the surviving myocardium after myocardial infarction (MI) and, consequently, to the recovery of cardiac function. 2 In response to pro-angiogenic stimuli, vascular endothelial cells need to be activated rapidly to migrate to distant sites and proliferate to form new primary capillaries from existing ones. 3, 4 Impaired angiogenic responses of endothelial cells have been linked to poor cardiac function and outcome after ACS clinically. Therefore, better understandings of the molecular mechanisms of angiogenesis provide a basis for therapeutic application in ACS patients.
MicroRNA is a kind of small, nonprotein-coding RNA that binds to specific 3′ untranslated regions (3′-UTR) of mRNA and represses target gene expression through inhibition of translation or transcript degradation. 5 In vascular cells, several microRNAs, such as miR-126, miR-217, miR-10a, miR-124, etc., have been identified to regulate multiple cellular functions including the glucose and lipid metabolisms, senescence and blood flow. [6] [7] [8] [9] We have previously reported that miR15b-5p regulates collateral artery formation by targeting protein kinase B in endothelial cells and miR-199 regulates normalise arachidonic acid metabolism in nitrate tolerance by prostaglandin synthase. 10, 11 Interestingly, endogenous expressions of miR-133a and miR-130, are null or very low in quiescent endothelial cells, while their expressions are ectopically induced by risk factors, resulting in endothelial dysfunction. 12, 13 These results indicate that expressional alterations of endogenous microRNAs are crucial to regulations of endothelial functions. However, the roles of microRNA in hypoxiainduced angiogenesis in endothelial cells remain poorly understood.
Based on the aforementioned studies, we tested the hypothesis that hypoxia affects endogenous microRNA expressions to promote angiogenesis in ischaemic heart. In this study, we firstly got 18 differentially expressed circulating microRNAs in plasma from ACS patients by using high-throughput sequencing and then identified the function of miR-185-5p as a key regulator of angiogenesis by targeting cathepsin K (CatK), which plays an important role in regulating vascular repair. 14 In vivo studies demonstrated that endogenous reduction of miR-185-5p was vital to the recovery of heart function after ischaemia in mice with MI. In perspectives, targeting miR-185-5p or CatK should be taken into consideration when treating ACS patients.
| MATERIALS AND METHODS
A full description of materials and methods used, including patient hsa-miR-378a-3p, hsa-miR-30b-5p, hsa-miR-425-5p, hsa-miR-23b-3p, hsa-miR-146b-5p, hsa-miR-877-5p, hsa-miR-99b-5p, hsa-miR-125a-5p, hsa-miR-5157-5p) were decreased.
Because miR-185-5p has been reported to inhibit angiogenesis and response to hypoxia, 17, 18 we chose miR-185-5p as a candidate to regulate angiogenesis and the recovery of heart function after MI.
Therefore, we confirmed the plasma levels of miR-185-5p by qPCR in 30 ACS patients (the demographic data were presented in Table S1 ).
As indicated in Figure 1B , plasma miR-185-5p levels were down-regulated in patients with ACS, compared to patients without ACS.
3.2 | MiR-185-5p is reduced in ischaemic heart in mice following MI
To determine whether miR-185-5p is vital to ischaemia-induced angiogenesis in heart, we performed FISH analysis to measure miR-185-5p expression in mice heart at 7 post-MI days. As depicted in Figure 1C , miR-185-5p expression was positively expressed in both cardio myocytes and endothelial cells under physiological condition. While, miR-185-5p expression in heart was remarkably reduced in ischaemic heart in mice with MI. The reduction of miR-185-5p expression in ischaemic heart was further confirmed by qPCR analysis ( Figure 1D ). Further, decreased miR-185-5p expression was associated with increased capillary intensity ( Figure 1E ), as indicated by quantitative analysis of CD31. These data suggest that miR-185-5p reduction may contribute to ischaemia-induced angiogenesis in heart.
| Hypoxia reduces miR-185-5p expression in endothelial cells
As the key cells of endothelial cells in angiogenesis, 19 we next exam- 
HUVECs under hypoxia
Tube formation is a vital step in endothelial cell-mediated angiogenesis. 20 Therefore, we examined if miR-185-5p regulates hypoxiainduced tube formation in HUVECs. As indicated in Figure 3C , E, As demonstrated in Figure 4A inhibits angiogenesis in ischaemic heart in vivo. To this point, mice
were infused with miR-185-5p agomir and were conducted with MI surgery ( Figure S5A ). Infusion of miR-185-5p agomir obviously increased miR-185-5p levels in hearts, compared with control agomir ( Figure S5B ). As indicated in Figure 6A , B, the capillary intensities in ischaemic area of hearts isolated from mice with MI after 28 postoperative days were significantly higher than hearts from mice with sham surgery, as determined by IHC analysis of CD31.
Treatment of miR-185-5p agomir but not control agomir completely reduced capillary numbers in mice with MI. Furthermore, administration of miR-185-5p agomir reduced fibrosis in ischaemic heart ( Figure 6A, C) . These results suggest that miR-185-5p reduction contributes to ischaemia-induced angiogenesis in mice after MI.
3.12 | MiR-185-5p agomir delays the recovery of heart functions in mice following MI Angiogenesis is a key regenerative event to recover the blood supply and to repair cardiac function in ACS patients. 25 Next, we determined whether miR-185-5p agomir delays the recovery of heart functions in mice following MI by echocardiographic analysis ( Figure 6D ). Echocardiographic parameters were shown in Table S2 .
Both EF and FS were dramatically decreased in mice with MI, which were further reduced by miR-185-5p agomir, compared to mice with negative agomir treatment ( Figure 6E, F) . We also detected the effects of CatK gene silencing on cardiac function in mice with MI by echocardiography and the echocardiographic parameters were shown in Table S3 . As expected, knockdown of CatK gene expression reduced EF and FS in mice infected with adenovirus expressing CatK shRNA at 28 postoperative days after MI surgery ( Figure S7D-F) . Taking these data together, it reveals that miR-185-5p/CatK axis plays a key role in angiogenesis and repair of heart function after MI.
3.15 | MiR-185-5p agonist and CatK inhibition suppress arteriogenesis in ischaemic heart isolated from mice with MI Growth of functional arteries from angiogenesis, which is driven by flow shear stress, is essential for the restoration of blood flow to ischaemic organs. 26, 27 Finally, we examined the roles of miR-185-5p
and CatK in arteriogenesis in mice heart by performing double staining of CD31 and ɑ-SMA shown in Figure S8A , B, either miR-185-5p Besides regulating angiogenesis, CatK, as a member of the lysosomal cysteine and aspartic proteinase family, has been shown to be one of the most potent mammalian collagenases. It plays a vital role in maintaining the homeostasis of extracellular matrix. 33 Pharmacological inhibition of CatK is a promising novel approach for postmenopausal osteoporosis therapy. 34 Overexpression of CatK in mice decreases collagen deposition and lung resistance in response to bleomycin-induced pulmonary fibrosis. 35 We further reported that CatK has some effects on the metabolism of collagen in the late stage of MI. This might be the reason why CatK is mediating a protective effect in cardiac function. Previous studies have reported that miR-185 plays important roles in regulation of cell proliferation and apoptosis in response to stress such as oscillating glucose. 36 As a tumour suppressive gene, miR-185 is a pivotal mediator in the cellular response to hypoxia, a state that directly affects angiogenesis. 37 In this study, we further uncovered the potential functions of miR-185 as a suppressor of angiogenesis in revascularisation in ischaemic heart by regulating CatK gene expression. Moreover, the miR-185-5p/CatK axis is a key mechanism contributing to the recovery of cardiac function after MI.
We demonstrated that miR-185-5p was a key regulation of revascularisation in heart after ischaemia, and may act as a potential therapeutic target in patients with ACS. As an endothelial rich microRNA, miR-185-5p is positive in blood and circulating miR-185 has been reported as a biomarker for clinical outcome in patients with dilated cardiomyopathy. 38 By using high-throughput RNA sequencing, we found 18 microRNAs including miR-185-5p in blood were differentially In summary, we identified that circulating miR-185-5p is substantially reduced in ACS patients. Endogenous inhibition of miR-185-5p
in endothelial cells promotes angiogenesis and accelerates the repair of heart function after MI through targeting CatK gene expression ( Figure S6D ). Therefore, modulation of CatK gene expression by miR-185-5p could be effective for an angiogenic therapy in treating ischaemic diseases, including MI, stroke, peripheral artery disease and wound healing in diabetes. 40 
